Newron Pharmaceuticals S.p.A.

NWPHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$6,933$6,338$13,424$25,019
Short-Term Investments$2,893$6,261$9,350$9,575
Receivables$42,423$2,530$1,944$1,308
Inventory$0$0$0$0
Other Curr. Assets$8,855$4,523$3,775$3,525
Total Curr. Assets$61,104$19,652$28,493$39,427
Property Plant & Equip (Net)$834$405$527$577
Goodwill$0$0$0$0
Intangibles$0$0$0$2
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,970$5,809-$527-$579
Total NC Assets$2,804$6,214$527$579
Other Assets$0$0$8,175$10,480
Total Assets$63,908$25,866$37,195$50,486
Liabilities
Payables$2,465$2,019$1,909$1,503
Short-Term Debt$13,553$22,452$172$150
Tax Payable$0$0$0$0
Deferred Revenue$0$0-$172-$150
Other Curr. Liab.$7,488$4,455$2,960$2,001
Total Curr. Liab.$23,506$28,926$5,041$3,654
LT Debt$36,916$25,963$45,490$42,931
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,028$885-$325-$389
Total NC Liab.$38,944$26,848$45,165$42,542
Other Liabilities$0$0$1,019$1,183
Cap. Leases$812$385$497$539
Total Liabilities$62,450$55,774$51,225$47,379
Equity
Pref Stock$0$12,081$0$0
Common Stock$3,992$3,569$3,569$3,569
Retained Earnings$10,685-$21,396-$22,805-$20,116
AOCI$0$0$5,206$14,553
Other Equity-$13,219-$24,162$0$5,101
Total Equity$1,458-$29,908-$14,030$3,107
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$63,908$25,866$37,195$50,486
Net Debt$43,536$42,077$32,238$18,062
Newron Pharmaceuticals S.p.A. (NWPHF) Financial Statements & Key Stats | AlphaPilot